• Wed news: BioNTech buying Biotheus. FDA’s Califf lists hopes for his successor. Amgen loses $12B market cap from hidden spreadsheet tab. TRex Bio raises $84M. London is Europe’s life science capitol. See more on our front page

Eisai and Biogen launch Alzheimer's drug Leqembi in China

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Jun 28, 2024 at 11:32: AM
via Eisai (4523.T) and Biogen (BIOAb.ST have launched their Alzheimer's treatment Leqembi in China, the third country after the United States and Japan, the companies said on Friday.

article source
 




Top Bottom
Back
Quote